AC
AGCO CORP /DE (AGCO)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 revenue was $2.89B, down 24% YoY, with adjusted EPS of $1.97 and adjusted operating margin of 9.9%; GAAP diluted EPS was $(3.42) due to a $364M goodwill impairment (largely PTx Trimble North America) and $131M restructuring and optimization expense .
- Regional mix and parts supported margins: EME delivered 14.4% operating margin in Q4 while parts revenue reached ~$418M, up ~4% YoY; North America margin was 0.7% given volume cuts and higher discounts .
- 2025 outlook reaffirmed: revenue ~$9.6B, adjusted operating margin 7.0–7.5%, EPS $4.00–$4.50; Q1 2025 revenue ~ $2.0B with EPS ~breakeven as AGCO front-loads production cuts to accelerate dealer destocking .
- Stock narrative catalysts: pace of dealer inventory normalization (NA ~9 months vs 6 target; SA ~5 vs 3) and realization of restructuring savings; monitoring PTx Trimble synergy ramp and any tariff developments flagged by management .
What Went Well and What Went Wrong
-
What Went Well
- Margin resiliency in a severe downturn: “Adjusted operating margin performance is by far our best performance in an industry downturn,” with Q4 adjusted OM at 9.9% and FY at 8.9% despite aggressive production cuts .
- Europe/Middle East execution: EME Q4 margin at 14.4%; CFO highlighted share gains, cost savings and “second highest level of earnings from the segment ever” despite volume pressure .
- Aftermarket and precision uptake: Parts revenue ~$418M in Q4, up ~4% reported and ~6% ex-FX; precision tech adoption strong (e.g., smart sprayer nozzle >50% Q4 take rate; >1,000 PTx dealers) .
-
What Went Wrong
- Top-line contraction: Q4 sales down 24% YoY and price modestly negative (~1%) amid broad end-market weakness; NA net sales down ~39% cc; APA and SA also sharply lower .
- GAAP losses driven by non-cash and strategic charges: $354.1M goodwill impairment (NA/PTx Trimble), and $507.3M loss on Grain & Protein divestiture contributed to Q4/FY losses .
- Channel inventory still elevated: Dealer inventory at ~9 months in NA (target 6) and ~5 months in SA (target 3); management plans to underproduce retail demand at least through 1H25 .
Financial Results
Headline results – sequential comparison (Q2–Q4 2024)
YoY comparison (Q4)
Segment/Regional breakdown – Q4 2024
KPIs and operational indicators
Non-GAAP adjustments – Q4 and FY
- Q4 adjusted EPS $1.97 vs GAAP $(3.42), primarily reflecting add-backs for $364.2M impairment (NA/PTx Trimble), $131.0M restructuring, $25.5M transaction costs, and $9.5M loss on sale; prior-year Q4 included Argentina FX devaluation and a Swiss tax benefit .
- FY24 adjusted EPS $7.50 vs GAAP $(5.69), adding back $507.3M loss on Grain & Protein divestiture, $369.5M impairments, $172.7M restructuring, $67.7M transaction costs and PTx Trimble amortization .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We delivered a strong 9.9% adjusted operating margin in Q4 and $1.97 in adjusted EPS, even as sales fell 24% and we cut production hours 33%...Our margin resiliency is clear evidence we’ve structurally improved the company through our transformation.” — Eric Hansotia, CEO .
- “North America is likely to be negative margin in Q1 given the level of underproduction; Europe low double-digit, South America slightly negative, APA low single-digit.” — Damon Audia, CFO .
- “There’s been a lot of progress...over 1,000 dealers and over 95% of acres covered with PTx technology...primary focus in 2025 is cross‑selling across full-line tech dealers.” — Eric Hansotia .
- On PTx Trimble impairment: “DCF timing with 2024 drop and 2025 outlook pressured near-term JV sales/earnings, leading to a write-down; long-term plan and adoption unchanged.” — Damon Audia .
Q&A Highlights
- Regional profitability cadence: Q1 2025 expected negative margin in North America and slightly negative in South America; Europe low double-digit; APA low single-digit, reflecting front-loaded underproduction to destock .
- Dealer inventory normalization: Europe near target; SA likely into Q2 to progress; NA depends on sentiment and commodity prices—company remains aggressive in monitoring days on hand and units .
- Pricing outlook: Slightly negative in Q1 due to European carryover and Argentina tax normalization; North America positive; full-year 2025 pricing still ~0–1% .
- Cost actions: On pace for $100–$125M run-rate savings by YE25; additional $75M run-rate by YE26 from centers of excellence; discretionary levers available if markets worsen .
- Tariff scenario planning: Multiple supply-chain scenarios prepared; expect minor direct effect from announced tariffs, with risk if retaliatory measures emerge .
Estimates Context
- We attempted to pull Wall Street consensus (S&P Global) for Q4 2024 revenue and EPS but the request limit was exceeded, so consensus data was unavailable at this time. As a result, we cannot quantify beat/miss versus S&P Global consensus for Q4 2024 and will update when the data is accessible.*
*Values retrieved from S&P Global could not be fetched due to a temporary limit; we will refresh upon availability.
Key Takeaways for Investors
- Margin quality held up: Adjusted OM of 9.9% in Q4 despite volume pressure underscores structural improvements and mix/aftermarket strengths .
- FY25 guide intact but conservative: ~$9.6B revenue, 7.0–7.5% adjusted OM and $4.00–$4.50 EPS maintained; Q1 trough signaled with breakeven EPS as production cuts are front-loaded .
- Inventory reset is the near-term swing factor: NA (~9 months) and SA (~5 months) dealer inventory need normalization; destocking trajectory will influence 2H25 recovery cadence and discounting .
- Precision strategy remains a long-term engine: Despite PTx goodwill impairment, channel breadth (>1,000 dealers) and retrofit-first offering position AGCO for growth as demand recovers .
- Watch Europe: EME margins are healthy with near-target dealer inventories; a stabilizing region could buffer volatility elsewhere .
- Capital discipline: Capex trimmed to ~$375M for 2025; free cash flow conversion target of 75%–100% reiterated as working capital normalizes with inventory sell-down .
- Policy risk monitoring: Potential tariff developments and retaliations remain a variable; management has contingency plans but will update the outlook as clarity improves .
Notes and Cross-References
- Q4 2024 press release and 8-K provide headline results, regional sales/margins, GAAP-to-non-GAAP reconciliations, and 2025 outlook .
- Q4 2024 earnings call transcript provides color on production cuts, dealer inventory, segment margin cadence, parts performance, pricing, tariffs and PTx Trimble commentary .
- Prior quarters for trend: Q3 2024 press release (sales $2.60B; adjusted EPS $0.68; adjusted OM 5.5%) ; Q2 2024 press release (sales $3.25B; adjusted EPS $2.53; adjusted OM 10.3%) .
- Strategic actions: Completion of Grain & Protein divestiture on Nov 1, 2024; proceeds applied to debt reduction .
- Long-term targets and initial 2025 outlook introduced at Dec 19, 2024 Analyst Meeting (maintained on Q4 release) .